MiMedX Group
eröffnet am 16.08.17 09:48:16 von
neuester Beitrag 01.05.24 16:50:11 von
neuester Beitrag 01.05.24 16:50:11 von
Beiträge: 35
ID: 1.259.427
ID: 1.259.427
Aufrufe heute: 0
Gesamt: 1.585
Gesamt: 1.585
Aktive User: 0
ISIN: US6024961012 · WKN: A0MS6X · Symbol: MDXG
7,8000
USD
-1,14 %
-0,0900 USD
Letzter Kurs 18.05.24 Nasdaq
Neuigkeiten
15.05.24 · globenewswire |
30.04.24 · globenewswire |
16.04.24 · globenewswire |
27.03.24 · globenewswire |
Werte aus der Branche Gesundheitswesen
Wertpapier | Kurs | Perf. % |
---|---|---|
7,0000 | +6.045,74 | |
0,8600 | +36,51 | |
0,8600 | +17,95 | |
33,95 | +14,31 | |
1,2900 | +12,17 |
Wertpapier | Kurs | Perf. % |
---|---|---|
5,73 | -14,96 | |
3,0100 | -17,31 | |
0,6000 | -18,92 | |
1,4500 | -21,62 | |
3,5800 | -24,79 |
Beitrag zu dieser Diskussion schreiben
Antwort auf Beitrag Nr.: 75.714.471 von Charly_2 am 01.05.24 16:48:02Mühsam ernährt sich das Eichhörnchen
https://finance.yahoo.com/news/q1-2024-mimedx-group-inc-1333…
Kursziel $12.50
Übernahme kommt früher!
https://finance.yahoo.com/news/q1-2024-mimedx-group-inc-1333…
Kursziel $12.50
Übernahme kommt früher!
Aktie abgesoffen, nach Zahlen bounce up
https://finance.yahoo.com/quote/MDXG/
https://finance.yahoo.com/quote/MDXG/
Report ist da
https://finance.yahoo.com/news/mimedx-group-inc-mdxg-reports…
Up
Nachbörslich $8.80 +0.60 (+7.32%)
https://finance.yahoo.com/news/mimedx-group-inc-mdxg-reports…
Up
Nachbörslich $8.80 +0.60 (+7.32%)
Aktie marschiert
PROFITABLE! Beat, Beat and Raise. Third quarter 2023 net sales of $81.7 million, an increase of 20.7% over third quarter 2022, beating estimate of $78.1 million. GAAP net income of $8.5 million for third quarter 2023, beating estimate of $5 million. Sales guidance raised from mid to high teens to high teens.
Drückerkolonne sollte sich verpissen
Drückerkolonne sollte sich verpissen
Antwort auf Beitrag Nr.: 74.243.853 von Charly_2 am 01.08.23 23:13:11Seit 1.1. +190.29%
Aktie legt zu
MIMEDX Announces Second Quarter 2023 Operating and Financial Results
MiMedx Group, Inc
Tue, August 1, 2023 at 10:01 PM GMT+2·15
MiMedx Group, Inc
Records Second Quarter Net Sales of $81.3 Million; an Increase of 21.5% Over the Prior Year Period
Increases Full-Year 2023 Guidance for Net Sales Growth
Welcomes Highly Successful MedTech Executive as Chief Financial Officer
Management to Host Conference Call on Tuesday, August 1, 2023, at 5:00 PM ET
MARIETTA, Ga., Aug. 01, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced operating and financial results for the second quarter 2023, which ended June 30, 2023, including net sales of $81.3 million, net income of $1.2 million and Adjusted EBITDA1 of $14.1 million.
MIMEDX Announces Second Quarter 2023 Operating and Financial Results
MiMedx Group, Inc
Tue, August 1, 2023 at 10:01 PM GMT+2·15
MiMedx Group, Inc
Records Second Quarter Net Sales of $81.3 Million; an Increase of 21.5% Over the Prior Year Period
Increases Full-Year 2023 Guidance for Net Sales Growth
Welcomes Highly Successful MedTech Executive as Chief Financial Officer
Management to Host Conference Call on Tuesday, August 1, 2023, at 5:00 PM ET
MARIETTA, Ga., Aug. 01, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced operating and financial results for the second quarter 2023, which ended June 30, 2023, including net sales of $81.3 million, net income of $1.2 million and Adjusted EBITDA1 of $14.1 million.
MDXG receives Notice of Allowance from US Patent Office for patent application 17/120,626 "Placental tissue grafts and improved methods of preparing and using the same"
Up 30% auf ~ 5 USD heute, 10 USD als Ziel
Up 30% auf ~ 5 USD heute, 10 USD als Ziel
15.05.24 · globenewswire · MiMedx Group |
30.04.24 · globenewswire · MiMedx Group |
16.04.24 · globenewswire · MiMedx Group |
27.03.24 · globenewswire · MiMedx Group |
20.03.24 · globenewswire · MiMedx Group |
13.03.24 · globenewswire · MiMedx Group |
04.03.24 · globenewswire · MiMedx Group |
28.02.24 · globenewswire · MiMedx Group |
20.02.24 · globenewswire · MiMedx Group |
12.02.24 · globenewswire · MiMedx Group |